Dexeus Mujer presents new evidence on gynecological cancer diagnosis and maternal-fetal health at the 36th ISUOG Congress

Dexeus Mujer presenta nuevas evidencias en el diagnóstico del cáncer ginecológico y la salud maternofetal en el 36º Congreso de la ISUOG

Dexeus Mujer presents new evidence on gynecological cancer diagnosis and maternal-fetal health at the 36th ISUOG Congress

Dexeus Mujer participated in the 36th World Congress on Ultrasound in Obstetrics and Gynecology (ISUOG), held in London from 4 to 7 September, presenting four scientific studies focusing on the risks of pregnancy in women aged 50 and over, fetal growth, and the usefulness of diagnostic imaging techniques in gynecological cancer. Conducted by specialists in Obstetrics, Prenatal Diagnosis and Gynecology, these studies provide new evidence to improve risk assessment and clinical decision-making.

In the field of Gynecological Diagnostic Imaging (DGI), two studies led by Dr M. Ángela Pascual and Dr Betlem Graupera, Head of R&D at the Dexeus Mujer Diagnostic Imaging Department, examine the role of ultrasound in diagnosing gynecological cancer. The first study reviews 26 years of experience using color Doppler transvaginal ultrasound to detect ovarian cancer. After analyzing nearly one million examinations performed on more than 242,000 women, the results show that a high proportion of the tumors detected were at an early stage. However, the authors emphasize the need for further research to confirm the usefulness of this technique as a screening tool. The second study, involving 120 patients with endometrial cancer, compares three-dimensional ultrasound with magnetic resonance imaging (MRI) for detecting cervical invasion. The results show that three-dimensional ultrasound has higher diagnostic sensitivity, suggesting its potential value in the preoperative assessment of these patients.

In the area of maternal-fetal health, a study led by Dr Pilar Prats, Head of R&D at the Dexeus Obstetrics Department, based on more than 45,000 deliveries, reveals that women giving birth at the age of 50 or older are more than twice as likely to experience maternal complications, even after adjusting for other risk factors. However, no statistically significant increase in the combined perinatal risk was observed. Another study, also presented by Dr. Prats, examines fetal growth using data from more than 21,000 singleton pregnancies and 710 twin pregnancies. The findings indicate that applying singleton fetal growth standards to twin pregnancies may lead to incorrect diagnoses of fetal growth restriction. The researchers therefore highlight the importance of using twin-specific growth charts that also account for fetal sex.

These studies highlight how research arising from clinical practice helps identify new risk factors, refine diagnostic tools and generate scientific evidence that contributes to improving patient care.

Dexeus Mujer presenta nuevas evidencias en el diagnóstico del cáncer ginecológico y la salud maternofetal en el 36º Congreso de la ISUOG

How can we help you?

We inform you that the personal data that you provide by filling in this form will be treated by Dexeus Mujer Foundation as responsible for this website. The purpose of collecting and processing this data is to contact you regarding your request and in the event that you expressly authorize us to send you information on activities, promotions and / or services and our periodic newsletter. The legitimation is carried out through the consent of the interested party. You can exercise your rights of access, rectification, limitation and delete the data before the data protection officer at dpd@dexeus.com as well as the right to file a claim with a control authority. You can consult the additional and detailed information on Data Protection in our privacy policy.